TXNIP and coronary artery disorder: Clinical genomic studies have linked variations in TXNIP transcript, elevated BP, arterial stiffness, and coronary heart disease, suggesting that imbalanced ceramide levels and subsequent TXNIP dysregulation may contribute to hypertension [29,30].